Open AccessPossibility to use barycytinib in patients with COVID-19, including for treatment of «cytokine storm»
Author(s) -
В. А. Отделенов,
V.M. Tsvetov Tsvetov,
Д. А. Сычёв
Publication year - 2020
Publication title -
kačestvennaâ kliničeskaâ praktika
Language(s) - English
Resource type - Journals
eISSN - 2618-8473
pISSN - 2588-0519
DOI - 10.37489/2588-0519-2020-s4-11-14
Subject(s) - cytokine storm , covid-19 , medicine , clinical trial , storm , intensive care medicine , virology , outbreak , meteorology , geography , infectious disease (medical specialty) , disease
Until clinical trials of efficacy and safety are obtained, routine use of barycytinib in patients with COVID-19 cannot be recommended.